M F Bakker

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. ncbi Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
    M F Bakker
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:iii56-60. 2007
  2. ncbi Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study
    M F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, Utrecht 3508 GA, The Netherlands
    Ann Rheum Dis 69:1849-52. 2010
  3. ncbi Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study
    M F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 70:1099-103. 2011
  4. ncbi The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial
    Marije F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Arthritis Res Ther 13:R70. 2011
  5. ncbi Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 69:1044-8. 2010
  6. ncbi Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    M C van der Goes
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands
    Osteoporos Int 24:1429-36. 2013

Detail Information

Publications6

  1. ncbi Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
    M F Bakker
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:iii56-60. 2007
    ..Tight control is a treatment strategy tailored to the individual patient with RA, which aims to achieve a predefined level of low disease activity or remission within a certain period of time...
  2. ncbi Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study
    M F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, Utrecht 3508 GA, The Netherlands
    Ann Rheum Dis 69:1849-52. 2010
    ....
  3. ncbi Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study
    M F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 70:1099-103. 2011
    ....
  4. ncbi The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial
    Marije F Bakker
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Arthritis Res Ther 13:R70. 2011
    ....
  5. ncbi Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 69:1044-8. 2010
    ....
  6. ncbi Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    M C van der Goes
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, PO Box 85500, 3508, GA, Utrecht, The Netherlands
    Osteoporos Int 24:1429-36. 2013
    ..A small increase in lumbar bone mineral density (BMD) during the first year of treatment was recorded, regardless of use of glucocorticoids...